Sun Pharma Advanced Research Company Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Mar ' 20

Sales

45.13

60.00

87.39

49.86

42.31

Operating profit

-193.65

-140.80

-77.81

-108.94

-152.07

Interest

0.52

4.49

4.55

8.78

1.83

Gross profit

-175.49

-145.05

-81.80

-111.44

-150.07

EPS (Rs)

-5.60

-5.54

-3.20

-4.42

-5.92

Other income

18.68

0.24

0.56

6.28

3.83

Stock adjustment

-

-

-

-

-

Raw material

11.64

11.28

10.05

8.22

9.40

Power and fuel

-

-

-

-

-

Employee expenses

61.83

50.37

47.32

49.46

47.14

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

165.31

139.15

107.83

101.12

137.84

Provisions made

-

-

-

-

-

Depreciation

6.28

5.70

5.09

5.07

4.98

Taxation

-

-

-

-

-

Net profit / loss

-181.77

-150.75

-86.89

-116.51

-155.05

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

32.45

27.19

27.19

26.35

26.21

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-429.09

-234.67

-89.04

-218.49

-359.42

GPM (%)

-275.02

-240.79

-93.01

-198.50

-325.25

NPM (%)

-284.86

-250.25

-98.79

-207.53

-336.04